首页|期刊导航|老年心脏病学杂志（英文版）|Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension
Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension
An-Hu WU Hui-Xia LU Zong-Wei LIN Zhuo-Hao YANG Hui ZHANG Jia-Yi HU Yi WANG Rui TANG Xin-Yu ZHANG Xiao-Ping JI
老年心脏病学杂志（英文版）2023，Vol.20Issue(12)：855-866,12.
老年心脏病学杂志（英文版）2023，Vol.20Issue(12)：855-866,12.DOI:10.26599/1671-5411.2023.12.005
Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension
Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension
摘要
引用本文复制引用
An-Hu WU,Hui-Xia LU,Zong-Wei LIN,Zhuo-Hao YANG,Hui ZHANG,Jia-Yi HU,Yi WANG,Rui TANG,Xin-Yu ZHANG,Xiao-Ping JI..Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension[J].老年心脏病学杂志（英文版）,2023,20(12):855-866,12.基金项目
This study was supported by the National Natural Sc-ience Foundation of China(No.81873516&No.821704-63),the National Key Research and Development Pr-ogram of China(2021YFF0501404&2021YFF0501403&2017YFC1308303),the Natural Science Foundation of Shandong Province(ZR2019PH030&ZR2019BH052),and the China International Medical Foundation(Z-2019-42-1908-2).All authors had no conflicts of interest to disclose.The authors would like to thank the patients,their families,and all investigators involved in this st-udy. （No.81873516&No.821704-63）
